CUSIP 21217B100CL ACTNMQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
79 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Suvretta Capital Management, LLC | 2.84M | $32.48M | +1.12M | Added |
| 2 | Janus Henderson Group PLC | 2.45M | $27.91M | +2.45M | New |
| 3 | Ra Capital Management, L.P. | 2.18M | $24.91M | +57.7K | Added |
| 4 | Johnson & Johnson | 1.98M | $22.62M |
| 0 |
| Held |
| 5 | Franklin Resources Inc | 1.88M | $21.48M | +223.8K | Added |
| 6 | Balyasny Asset Management L.P. | 1.84M | $21.06M | +891.5K | Added |
| 7 | Perceptive Advisors LLC | 1.46M | $16.74M | +750.0K | Added |
| 8 | Baker Bros. Advisors LP | 1.42M | $16.24M | +1.34M | Added |
| 9 | Vanguard Group Inc | 1.27M | $14.53M | +306.6K | Added |
| 10 | Millennium Management LLC | 830.7K | $9.49M | +184.7K | Added |
See every fund holding Contineum Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders